Royal bank of scotland (rbs)
US insurers' mortality exposure encourages diversification with UK longevity risks
Royal Bank of Scotland keeps investor products and equity derivatives in latest restructuring, but ditches cash equities, corporate broking, equity capital markets and M&A
More Royal bank of scotland (rbs) articles
Lance Uggla, chief executive of Markit, pauses a moment and opens a door: “You should see this,” he says. It’s impossible to know what lies behind that door, but the financial information services company Uggla founded with four former colleagues...
The inflation derivatives market is characterised by long-dated trades, big notional sizes, a lack of liquidity and – where corporate clients are involved – a lack of collateral. In other words, it is exactly the kind of business that will be punished...
Ever-increasing sanctions are creating operational challenges not only for sanctioned entities but the industry as a whole
Tim Mortimer of Future Value Consultants reviews a healthy revival in interest for leveraged return notes from US investors, as well as HSBC’s position as the leading provider of structured products in the US in October. Investec, again, head the issuance...
Volatility revisited equity markets in August and September, which meant Germany’s much-loved bonus certificates hit barriers, creating much inconvenience to retail investors. Bonuses have been adapted to cope but are less popular than discount certificates,...
In response to industry fears of a collateral crunch, regulators have revised the proposed rules on margining for uncleared over-the-counter (OTC) derivatives.You can find out more by downloading this white paper here.
Topics of interest
Hong Kong, 1st - 31st Dec 2014
UK, 18th Mar 2015
Singapore, 22nd - 23rd Jul 2014
Australia, 12th - 13th Aug 2014
Australia, 14th Aug 2014